DDInter187 DDInter1376
A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
Ozanimod is a once-daily sphingosine 1-phosphate receptor modulator for the treatment of relapsing Multiple Sclerosis (MS) and inflammatory bowel disease. It was developed by Celgene (now acquired by Bristol-Myers Squibb) and was approved by the FDA on March 26, 2020.[L12573,L12582] The US approval was followed by the approval in Canada on October 2, 2020. In November 2021, ozanimod was also approved by the European Commission for the treatment of adults with relapsing remitting multiple sclerosis.[L39377,L39382] MS is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Inflammatory bowel disease also a chronic inflammatory condition and can cause persistent abdominal pain, diarrhea, bloody stools, and vomiting. In clinical trials, Ozanimod has been shown to be well-tolerated and has resulted in a higher decrease in the rate of MS relapses than with intramuscular [interferon beta-1a], a current standard in MS therapy. Studies involving patients with inflammatory bowel disease have also shown promising results.[A189318,A189342]
Benzphetamine {u} (Compound) resembles {v} (Compound) Metamfetamine
Benzphetamine {u} (Compound) resembles {v} (Compound) Amphetamine
Benzphetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Promethazine
Benzphetamine {u} (Compound) treats {v} (Disease) obesity
Benzphetamine {u} (Compound) binds {v} (Gene) SLC18A2
Benzphetamine {u} (Compound) is included by {v} (Pharmacologic Class) Increased Sympathetic Activity
Benzphetamine {u} (Compound) causes {v} (Side Effect) Headache
Benzphetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lindane
Benzphetamine {u} may lead to a major life threatening interaction when taken with {v} Bupropion
Benzphetamine {u} may lead to a major life threatening interaction when taken with {v} Phentermine
Benzphetamine (Compound) resembles Metamfetamine (Compound)
Benzphetamine (Compound) resembles Amphetamine (Compound)
Benzphetamine may cause a moderate interaction that could exacerbate diseases when taken with Promethazine
Benzphetamine (Compound) treats obesity (Disease)
Benzphetamine (Compound) binds SLC18A2 (Gene)
Benzphetamine (Compound) is included by Increased Sympathetic Activity (Pharmacologic Class)
Benzphetamine (Compound) causes Headache (Side Effect)
Benzphetamine may cause a moderate interaction that could exacerbate diseases when taken with Lindane
Benzphetamine may lead to a major life threatening interaction when taken with Bupropion
Benzphetamine may lead to a major life threatening interaction when taken with Phentermine